Presented by Georgios Karagkounis at the SS05: Colorectal 1 held during the 2017 SAGES Annual Meeting in Houston, TX on Wednesday, March 22, 2017
Keyword(s): ASCRS, cancer initiating cells, CD44 gene, CICs, colorectal cancer, endpoints, in vitro, long-term outcomes, neoadjuvant chemoradiation, radiation sensitivity, rectal cancer, Simvastatin, statin therapy, survival, tumor
Rectal cx response to chemoradiation predicts survival–5 sec Dis Colon Rectum 2015
Statin therapy & rectal cx–27 sec Dis Colon Rectum 2013
Cx initiating cell model–50 sec Nature 2007
Resistance to radiation is assoc. with CIC activity–1:35
Hypothesis–2:04
Experimental approach–2:17
Summary–5:39
Conclusion–6:08
Acknowledgements–6:26
Q&A session–6:50